Base case scenario for me is clbp trial gets the tick repeating the statistical significance for the pain reduction end point (12 months)demonstrated in the prior trial. An earlier approval for paediatrics gvhd would be a swell suprise. Here's to hoping anyway!
Ann: MSB Launches Entitlement Offer and Placement, page-125
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.3¢ |
Change
-0.013(1.30%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $1.239M | 1.295M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 345342 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 66873 | 48 |
View Market Depth
| Last trade - 13.54pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |